HUSSMAN STRATEGIC ADVISORS, INC. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$205,920
-12.0%
156,0000.0%0.03%
-15.8%
Q4 2022$234,000
+27.2%
156,0000.0%0.04%
+18.8%
Q3 2022$184,000
+4.5%
156,0000.0%0.03%
+6.7%
Q2 2022$176,000
-62.2%
156,0000.0%0.03%
-66.7%
Q1 2022$466,000
+12.8%
156,0000.0%0.09%
-1.1%
Q4 2021$413,000156,0000.09%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders